Low Rate of Production of Apolipoproteins B100 and AI in 2 Patients With Anderson Disease (Chylomicron Retention Disease)
Author(s) -
Khadija Ouguerram,
Yassine Zaïr,
Fatima Kasbi-Chadli,
Hassan Nazih,
Dominique Bligny,
Jacques Schmitz,
Thomas Aparicio,
Maud Chétiveaux,
T. Magot,
Laurence P. Aggerbeck,
Marie Elisabeth Samson-Bouma,
Michel Krempf
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.245076
Subject(s) - medicine , hypocholesterolemia , apolipoprotein b , endocrinology , chylomicron , catabolism , lipoprotein , high density lipoprotein , cholesterol , very low density lipoprotein , chemistry , triglyceride , metabolism
Anderson disease is a rare inherited lipid malabsorption syndrome associated with hypocholesterolemia and linked to SAR1B mutations. The aim of this article was to analyze the mechanisms responsible for the low plasma apolipoprotein Apo-B100 and Apo-AI in 2 patients with Anderson disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom